Cartiva’s Challenge: Moving the Market with a First-in-Class Motion-Preserving Toe Implant

article image
ARTICLE SUMMARY:

Cartiva’s synthetic cartilage implant for osteoarthritis of the great toe is the first PMA-approved device for the forefoot, illustrating both the complexities and advantages of undertaking a lengthy and costly path to market that, having long been considered a niche, is fast gaining mainstream attention.

Osteoarthritis of the great toe, or hallux rigidus, is the most common arthritis in the foot, affecting almost three million people.

×

This article is restricted to subscribers only.

Sign in to continue reading.

Questions?

We're here to help! Please contact us at: